H
H

Hikma

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

UK Stocks-Factors to watch on April 30

Britain's FTSE 100 .FTSE index is seen opening 13 points lower at 6,949 on Friday, according to financial bookmakers, with futures FFIc1 seen down 0.2% ahead of cash market open. * ASTRAZENECA: AstraZeneca AZN.L said its COVID-19 vaccine contributed $275 million in sales and shaved off three cents per share from its first-quarter earnings, as the d
A
B
H
W
S
U

UK Stocks-Factors to watch on April 30

Britain's FTSE 100 .FTSE index is seen opening 13 points lower at 6,949 on Friday, according to financial bookmakers. * ASTRAZENECA: Denmark's top health official said on Thursday "the only ethical, correct decision" for some countries facing COVID-19 crises is to continue giving AstraZeneca's AZN.L vaccine, though his nation halted use over very r
A
B
H
W
S
U

UK Stocks-Factors to watch on Feb. 25

Feb 25 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening 32 points higher at 6,691 on Thursday, according to financial bookmakers, with futures .FFIc1 up 0.41% ahead of cash market open. * CENTRICA: Centrica CNA.L reported a 362 million pound loss from continuing operations for 2020, due to the impacts of coronavirus, warmer weather and we
B
C
D
H
S
S
A
A
U

UK Stocks-Factors to watch on Feb. 25

Feb 25 (Reuters) - Britain's FTSE 100 index .FTSE is seen opening 32 points higher at 6,691 on Thursday, according to financial bookmakers. * STANDARD CHARTERED: Standard Chartered Plc STAN.L posted a 57% fall in annual profit, missing analyst estimates, on higher credit impairments due to the COVID-19 pandemic. * GOLD: Gold eased as U.S. Treasury
B
C
D
E
H
H
I
M
S
S
A
U

Healthcare drags FTSE 100 down; Vodafone jumps

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * GlaxoSmithKline slumps on COVID-19 vaccine development * Vodafone gains after earnings beat estimates * Glencore rises after maintaining 2021 output targets * FTSE 100 down 0.1%, FTSE 250 adds 0.3% (Updates to close) By Shashank Nayar, Ama
A
A
G
G
H
V
N
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.